Skip to content
Insider tapeFilings through Fri, Nov 20
My stocks

Glenn Coleman

At a glance: Glenn Coleman is CFO at Charles River Laboratories (CRL). Their latest SEC Form 4, filed Oct 2, 2026, reported a purchase of $3K. On file: 1 purchase line ($3K) and 0 sale lines ($0).

Disclosed holdings: about $8.7M of CRL stock: 27,762 shares reported on their latest Form 4 (filed Oct 2, 2026), valued at the Nov 20, 2026 close of $314.32. This counts only CRL shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CFO at Charles River Laboratories International, Inc. (CRL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$169
Total bought / sold$3K / $0

Glenn Coleman's InsiderPrint

2 trades from SEC Form 4 filings, 2023 to 2026, drawn as one fingerprint.

InsiderPrint of Glenn Coleman: 2 trades, 2023 to 20262023: 1 buy, 0 sales2024: 0 buys, 0 sales2025: 0 buys, 0 sales2026: 1 buy, 0 sales
  • Bump outward: a purchase (2)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Oct 2SEC CRLCharles River Laboratories International, Inc.First buy Buy 1027,762 held (+0%) $297.43 $3K +5.7%
  • Buy

    CFO Glenn Coleman bought $3K of CRL at $297.43 — first open-market purchase in our records.

Follow Glenn Coleman

Get one email when Glenn Coleman files a new purchase or sale. Free.

At most one email a day about Glenn Coleman, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.